Clinical ascertainment of health outcomes among adults treated for childhood cancer.

IMPORTANCE Adult survivors of childhood cancer are known to be at risk for treatment-related adverse health outcomes. A large population of survivors has not been evaluated using a comprehensive systematic clinical assessment to determine the prevalence of chronic health conditions. OBJECTIVE To determine the prevalence of adverse health outcomes and the proportion associated with treatment-related exposures in a large cohort of adult survivors of childhood cancer. DESIGN, SETTING, AND PARTICIPANTS Presence of health outcomes was ascertained using systematic exposure-based medical assessments among 1713 adult (median age, 32 [range, 18-60] years) survivors of childhood cancer (median time from diagnosis, 25 [range, 10-47] years) enrolled in the St Jude Lifetime Cohort Study since October 1, 2007, and undergoing follow-up through October 31, 2012. MAIN OUTCOMES AND MEASURES Age-specific cumulative prevalence of adverse outcomes by organ system. RESULTS Using clinical criteria, the crude prevalence of adverse health outcomes was highest for pulmonary (abnormal pulmonary function, 65.2% [95% CI, 60.4%-69.8%]), auditory (hearing loss, 62.1% [95% CI, 55.8%-68.2%]), endocrine or reproductive (any endocrine condition, such as hypothalamic-pituitary axis disorders and male germ cell dysfunction, 62.0% [95% CI, 59.5%-64.6%]), cardiac (any cardiac condition, such as heart valve disorders, 56.4% [95% CI, 53.5%-59.2%]), and neurocognitive (neurocognitive impairment, 48.0% [95% CI, 44.9%-51.0%]) function, whereas abnormalities involving hepatic (liver dysfunction, 13.0% [95% CI, 10.8%-15.3%]), skeletal (osteoporosis, 9.6% [95% CI, 8.0%-11.5%]), renal (kidney dysfunction, 5.0% [95% CI, 4.0%-6.3%]), and hematopoietic (abnormal blood cell counts, 3.0% [95% CI, 2.1%-3.9%]) function were less common. Among survivors at risk for adverse outcomes following specific cancer treatment modalities, the estimated cumulative prevalence at age 50 years was 21.6% (95% CI, 19.3%-23.9%) for cardiomyopathy, 83.5% (95% CI, 80.2%-86.8%) for heart valve disorder, 81.3% (95% CI, 77.6%-85.0%) for pulmonary dysfunction, 76.8% (95% CI, 73.6%-80.0%) for pituitary dysfunction, 86.5% (95% CI, 82.3%-90.7%) for hearing loss, 31.9% (95% CI, 28.0%-35.8%) for primary ovarian failure, 31.1% (95% CI, 27.3%-34.9%) for Leydig cell failure, and 40.9% (95% CI, 32.0%-49.8%) for breast cancer. At age 45 years, the estimated cumulative prevalence of any chronic health condition was 95.5% (95% CI, 94.8%-98.6%) and 80.5% (95% CI, 73.0%-86.6%) for a serious/disabling or life-threatening chronic condition. CONCLUSIONS AND RELEVANCE Among adult survivors of childhood cancer, the prevalence of adverse health outcomes was high, and a systematic risk-based medical assessment identified a substantial number of previously undiagnosed problems that are more prevalent in an older population. These findings underscore the importance of ongoing health monitoring for adults who survive childhood cancer.

[1]  C. Moorehead All rights reserved , 1997 .

[2]  Monique W M Jaspers,et al.  Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. , 2007, JAMA.

[3]  Robert D Frisina,et al.  Age‐related Hearing Loss , 2009, Annals of the New York Academy of Sciences.

[4]  K. Matthay,et al.  Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors , 2013, Pediatric blood & cancer.

[5]  K. Ness,et al.  Assessment of potential bias from non‐participation in a dynamic clinical cohort of long‐term childhood cancer survivors: Results from the St. Jude lifetime cohort study , 2013, Pediatric blood & cancer.

[6]  P. Allison Survival analysis using the SAS system : a practical guide , 1995 .

[7]  Angela B Mariotto,et al.  Cancer Survivors: A Booming Population , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[8]  A. Mariotto,et al.  Burden of illness in adult survivors of childhood cancers , 2010, Cancer.

[9]  C. Pui,et al.  Lessons from the past: Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies , 2012, Pediatric blood & cancer.

[10]  J. Marín-García,et al.  Cardiomyopathy and Heart Failure in Aging , 2008 .

[11]  A. Toschke,et al.  An illustration of and programs estimating attributable fractions in large scale surveys considering multiple risk factors , 2009 .

[12]  A. Mertens,et al.  Severity of health conditions identified in a pediatric cancer survivor program , 2010, Pediatric blood & cancer.

[13]  B. Wolffenbuttel,et al.  The metabolic syndrome in cancer survivors. , 2010, The Lancet. Oncology.

[14]  P. Asbell,et al.  Age-related cataract , 2005, The Lancet.

[15]  Wendy Leisenring,et al.  Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. , 2008, Journal of the National Cancer Institute.

[16]  Xiaomei Ma,et al.  New health conditions identified at a regional childhood cancer survivor clinic visit , 2013, Pediatric blood & cancer.

[17]  G. Armstrong,et al.  Prospective medical assessment of adults surviving childhood cancer: Study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort Study , 2011, Pediatric blood & cancer.

[18]  E. Lancashire,et al.  Health care use of long-term survivors of childhood cancer: the British Childhood Cancer Survivor Study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  S. Bhatia,et al.  Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  L. Robison,et al.  Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. , 2010, Blood.

[21]  E. Glisky Changes in Cognitive Function in Human Aging , 2007 .

[22]  C. Pui,et al.  Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy. , 2013, Journal of the National Cancer Institute.

[23]  J. Stockman,et al.  Chronic Health Conditions in Adult Survivors of Childhood Cancer , 2008 .